Literature DB >> 18295051

Critical missing data on erythropoiesis-stimulating agents in CKD: first beat placebo.

Marc A Pfeffer.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18295051     DOI： 10.1053/j.ajkd.2008.01.003

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  4 in total

1.  Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease.

Authors:  Natalie A Bello; Eldrin F Lewis; Akshay S Desai; Inder S Anand; Henry Krum; John J V McMurray; Kurt Olson; Scott D Solomon; Karl Swedberg; Dirk J van Veldhuisen; James B Young; Marc A Pfeffer
Journal:  Eur J Heart Fail       Date:  2015-10-01       Impact factor: 15.534

2.  Nadir hemoglobin levels after discontinuation of epoetin in hemodialysis patients.

Authors:  Jose A Calvo; Dana C Miskulin; Klemens B Meyer; Daniel E Weiner
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 8.237

Review 3.  Cardiovascular risk and management in chronic kidney disease.

Authors:  Diana Rucker; Marcello Tonelli
Journal:  Nat Rev Nephrol       Date:  2009-05       Impact factor: 28.314

Review 4.  Emerging therapies for chronic kidney disease: what is their role?

Authors:  Eswari Vilayur; David C H Harris
Journal:  Nat Rev Nephrol       Date:  2009-05-19       Impact factor: 28.314
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.